GENE ONLINE|News &
Opinion
Blog

Keytruda
Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Trials & Approvals Merck
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
Merck
Merck Reportedly Interested in Potential $40 Billion SeaGen Buyout
2022-07-08
Supply Chain
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Trials & Approvals Cancer
Merck Breaks Off Keytruda Combo Trial with AstraZeneca, Begins Another with Imugene
2022-03-16
Breast Cancer
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Trials & Approvals Keytruda
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Trials & Approvals Immunotherapy
Merck’s Keytruda Shows Survival Benefit as Adjuvant Therapy in Stage II Melanoma
2021-08-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
Trials & Approvals Anti-PD-1
Merck’s Anti-PD1 Therapy Receives Second FDA Approval for Esophageal Carcinoma
2021-03-25
Autoimmune Disease
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Trials & Approvals PD-1 Inhibitor
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Trials & Approvals Renal Cell Carcinoma
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
CAR-T Technology
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
Trials & Approvals ESCC
Keytruda Receives Two New Approvals in Japan
2020-08-30
1 2 3
LATEST
Trident Gold Corp. Reports 4.61 g/t Gold Over 38.48 Meters at Contact Lake Property
2026-04-15
Molecular Monitoring Is Changing Cancer Care—But Intervention Still Lags
2026-04-15
40 Percent of Commercially Insured Individuals Affected by Copay Accumulator and Maximizer Programs in 2025
2026-04-15
Medicare Part D Enrollment Data for 2026 Shows 83% of Seniors in Plans with Preferred Pharmacy Networks
2026-04-15
Hybrid Hub Models on the Rise as 2026 Patient Services Report Highlights Technology Gaps and Interoperability Challenges
2026-04-15
Mark Cuban Comments on FTC Settlement with Express Scripts Amid 340B Program’s Role in Hospital Consolidations
2026-04-15
Pharmaceutical Experts Advocate for Flexible Hybrid Models to Replace One-Size-Fits-All DTP Programs
2026-04-15
READ MORE
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
2026-05-11
ASGCT (Gene and Cell Therapy Advances)
Boston, Massachusetts
2026-05-29
ASCO 2026 (Major Oncology Clinical Data)
Chicago, Illinois
2026-06-22
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
2026-06-25
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
SEE MORE
Scroll to Top